The International Organization for Standardization (ISO) has published the new EN ISO 22964:2017 standard, which specifies a horizontal method for the detection of Cronobacter spp. in food, animal feed and environmental samples.
It is applicable to food products and ingredients intended for human consumption and the feeding of animals, and environmental samples in the area of food production and food handling. Compared to the previous ISO/TS 22964:2006, the main changes are considered as major. In the new EN ISO 22964:2017, the scope has been extended to detect Cronobacter spp. according to new taxonomy from 2014.
Cronobacter spp. are those microorganisms which form typical colonies on chromogenic Cronobacter isolation (CCI) agar and which display the described biochemical characteristics when tests are carried out in accordance with this new standard.
To enable customers to follow EN ISO 22964:2017, We have released the newly described Cronobacter Selective Broth (CSB) and CCI agar products.
As a worldwide leading provider of a broad range of dehydrated granulated and ready-to-use culture media for food, beverages and water microbiology, we closely track and support the development of relevant standards aimed at increasing consumer confidence and safety. Our GranuCult® granulated media, Readybag® pre-weighed granulated media in ready-to-use bags, ReadyPlate™, and ReadyTube™ ready-to-use media are all compliant with EN ISO 11133:2014 and the specific standards. All information regarding compliance with additional reference standards are displayed on the product label and in the product’s technical information available on our website.
We have implemented all the requirements described in the new EN ISO 22964. The following culture media and accessories described in the new EN ISO 22964:2017 are available – Materials Table.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.